Paul Hastings Nominated for Four LMG Life Sciences Awards
July 26, 2019
Paul Hastings Recognized in 2019 Managing Intellectual Property’s IP Stars
June 24, 2019
Paul Hastings Recognized in 2019 IAM Patent 1000 as One of the Most Sophisticated Patent Litigation Practices
June 07, 2019
Paul Hastings Wins Top Honors at 2019 Managing IP Americas Awards
April 08, 2019
Paul Hastings Scores Top Rankings in LMG Life Sciences for 2018
October 11, 2018
Paul Hastings Wins Hatch-Waxman Litigation Firm of the Year at LMG Life Sciences Awards
September 13, 2018
Paul Hastings Recognized in 2018 Managing Intellectual Property IP Stars
June 18, 2018
Paul Hastings Wins Law360 Life Sciences Practice Group of the Year
February 05, 2018
IP Boom Continues at Paul Hastings with Life Sciences and Technology Partner Addition
July 18, 2016
Takeaways from Federal Circuit’s Decision in UCB v. Accord on Obviousness of Chemical Compounds
June 04, 2018
Life Sciences & Antitrust: Cases to Watch in 2018
January 17, 2018
Five Takeaways from Combination Drug Treatment and Dissolution Range Patent Rulings in Orexigen v. Actavis
October 17, 2017
Reading the Tea Leaves from the TC Heartland LLC v. Kraft Food Group Brands LLC Oral Argument
March 30, 2017
Beyond Pay-for-Delay: Three Pharma Antitrust Cases To Watch In 2017
February 16, 2017
Recognized by Managing IP as the Life Sciences IP Litigation Firm of the Year
Paul Hastings was was recognized by Managing IP at their Americas Awards, which honored individuals and companies behind the most innovative and challenging IP work of the past year, as well as those driving the international IP market.
The firm was recognized as Life Sciences IP Litigation Firm of the Year in the United States.
April 05, 2019
Recognized as LMG Life Sciences Stars for 2018
Paul Hastings was recognized in the 2018 edition of LMG Life Sciences, with Highly Recommended rankings for General Patent Litigation and Hatch-Waxman Branded Litigation. LMG Life Sciences selected seven individual lawyers as "Life Sciences Stars," including Eric Dittmann, Gary Giampetruzzi, Naveen Modi, Joseph O’Malley, Chad Peterman, Preston Ratliff, and Bruce Wexler. Earlier this year, LMG Life Sciences honored the firm with the LMG Life Sciences award for Hatch-Waxman Litigation Firm of the Year – Branded.
October 12, 2018
Recognized as the Hatch-Waxman Litigation Firm of the Year by LMG Life Sciences
LMG Life Sciences announced that the firm’s Intellectual Property practice was honored at the LMG Life Sciences Awards as the Hatch-Waxman Litigation Firm of the Year (Branded). The publication cited the firm for wins on behalf of Sunovion Pharmaceuticals, which locked in compound patent protection for Latuda®, the company’s billion-dollar-plus-per-year schizophrenia and bipolar drug, after a judgment of infringement that was affirmed by the Federal Circuit; and for Orexigen Therapeutics after a trial victory where the judge found all three patents-in-suit to be valid and infringed. The firm was also noted for obtaining an unprecedented six walk-away consent judgments in a major pharmaceutical litigation.
The firm and its partners were also shortlisted for:
* Inter-Partes Review Firm of the Year
* Post Grant Proceedings Attorney of the Year: Naveen Modi
* General Patent Litigator of the Year – New York: Bruce Wexler
September 13, 2018
Recognized as LMG Life Sciences Stars for 2017
Paul Hastings was recognized in LMG Life Sciences, with Highly Recommended rankings for General Patent Litigation and Hatch-Waxman Branded Litigation.
LMG Life Sciences selected seven individual lawyers as "Life Sciences Stars," including Joseph O’Malley, Bruce Wexler, Gerald Flattmann, Naveen Modi, Chad Peterman, Eric Dittmann, and Gary Giampetruzzi.
October 06, 2017